Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder

The PHQ-9: Validity of a brief depression severity measure

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910

The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712

The PHQ-9: A New Depression Diagnostic and Severity Measure

Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898

Untitled work

(1962) · Medical Entomology and Zoology · Cited by 4,856

The Obsessive-Compulsive Inventory: Development and validation of a short version.

Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002) · Psychological Assessment · doi:10.1037/1040-3590.14.4.485 · Cited by 2,959

The Yale-Brown Obsessive Compulsive Scale: II. Validity

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799

The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity

LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146

Untitled work

(1993) · PubMed · Cited by 1,900

The measurement of disability

Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]

(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: Towards an Individualized Approach

Senova, S., Clair, A.-H., Palfi, S., Yelnik, J., Domenech, P., & Mallet, L. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00905 · Cited by 59

Wellbeing-enhancing occupation and organizational and environmental contributors in long-term dementia care facilities: an explorative study

Smit, D., Willemse, B. M., de Lange, J., & Pot, A. M. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001397 · Cited by 56

Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder

Wheaton, M. G., Gershkovich, M., Gallagher, T., Foa, E. B., & Simpson, H. B. (2018) · Depression and Anxiety · doi:10.1002/da.22720 · Cited by 56

Treatment of Obsessive-Compulsive Disorder Complicated by Comorbid Eating Disorders

Simpson, H. B., Wetterneck, C. T., Cahill, S. P., STEINGLASS, J. E., Franklin, M. E., Leonard, R. C., Weltzin, T. E., & Riemann, B. C. (2013) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2012.751124 · Cited by 55

Regional homogeneity of spontaneous brain activity in adult patients with obsessive–compulsive disorder before and after cognitive behavioural therapy

Yang, X., Sun, J., Luo, J., Zhong, Z., Li, P., Yao, S., Xiong, H., Huang, F.-F., & Li, Z. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.048 · Cited by 57

Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment

Zink, M. (2014) · Advances in Medicine · doi:10.1155/2014/317980 · Cited by 55

Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial

Modarresi, A., Sayyah, M., Razooghi, S., Eslami, K., Javadi, M., & Kouti, L. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-120268 · Cited by 56

Transitioning to virtual programming amidst COVID-19 outbreak

Sequeira, A., Alozie, A., Fasteau, M., Lopez, A. K., Sy, J. T., Turner, K. A., Werner, C., McIngvale, E., & Björgvinsson, Þ. (2020) · Counselling Psychology Quarterly · doi:10.1080/09515070.2020.1777940 · Cited by 54

Out on a Limb: The Ethical Management of Body Integrity Identity Disorder

Ryan, C. J. (2008) · Neuroethics · doi:10.1007/s12152-008-9026-4 · Cited by 54

OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding

Pittenger, C., Adams, T. G., Gallezot, J., Crowley, M. J., Nabulsi, N., Ropchan, J., Gao, H., Kichuk, S. A., Simpson, R., Billingslea, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.021 · Cited by 55

A randomized controlled trial comparing EMDR and CBT for obsessive–compulsive disorder

Marsden, Z., Lovell, K., Blore, D. C., Ali, S., & Delgadillo, J. (2017) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2120 · Cited by 62

Neuromodulation in Obsessive-Compulsive Disorder

Bais, M., Figee, M., & Denys, D. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.06.003 · Cited by 53

Effect of unawareness on rehabilitation outcome in a randomised controlled trial of multicomponent intervention for patients with mild Alzheimer's disease

Fernández‐Calvo, B., Contador, I., Ramos, F., Olazarán, J., Mograbi, D. C., & Morris, R. G. (2014) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2014.948461 · Cited by 53

A Placebo-Controlled Trial of Dextromethorphan as an Adjunct in Opioid-Dependent Patients Undergoing Methadone Maintenance Treatment

Lee, S.-Y., Chen, S., Chang, Y. H., Chu, C.-H., Chen, S.-H., Chen, P. S., Huang, S., Tzeng, N., Wang, L., Lee, I. H., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv008 · Cited by 53

Ecopsychosocial Interventions in Cognitive Decline and Dementia

Zeisel, J., Reisberg, ‌., Whitehouse, P. J., Woods, B. T., & Verheul, A. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317516650806 · Cited by 53

Magnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression

Aizenstein, H. J., Khalaf, A. M., Walker, S. E., & Andreescu, C. (2013) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516541 · Cited by 56

Beta-Blocker Propranolol Modulates Decision Urgency During Sequential Information Gathering

Hauser, T. U., Moutoussis, M., Purg, N., Dayan, P., & Dolan, R. J. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0192-18.2018 · Cited by 52

Pharmacotherapeutic Strategies and New Targets in OCD

Pittenger, C. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_204 · Cited by 54

App-guided exposure and response prevention for obsessive compulsive disorder: an open pilot trial

Boisseau, C. L., Schwartzman, C. M., Lawton, J., & Mancebo, M. C. (2017) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2017.1321683 · Cited by 51

Brain regions related to fear extinction in obsessive-compulsive disorder and its relation to exposure therapy outcome: A morphometric study

Fullana, M. A., Cardoner, N., Alonso, P., Subirà, M., López-Solà, C., Pujol, J., Segalàs, C., Real, E., Bossa, M., Zacur, E., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291713001128 · Cited by 50

Assessing the validity of current mouse genetic models of obsessive-compulsive disorder

Wang, L., Simpson, H. B., & Dulawa, S. C. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a80ad · Cited by 50

BCHE and CYP2D6 genetic variation in Alzheimer’s disease patients treated with cholinesterase inhibitors

Chianella, C., Gragnaniello, D., Delser, P. M., Visentini, M. F., Sette, E., Tola, M. R., Barbujani, G., & Fuselli, S. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1064-x · Cited by 50

Differential effects of antipsychotic agents on obsessive–compulsive symptoms in schizophrenia: a longitudinal study

Schirmbeck, F. N., Rausch, F., Englisch, S., Eifler, S., Esslinger, C., Meyer‐Lindenberg, A., & Zink, M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112463470 · Cited by 50

Mindfulness-based exposure and response prevention for obsessive compulsive disorder: Findings from a pilot randomised controlled trial

Strauss, C., Lea, L., Hayward, M., Forrester, E., Leeuwerik, T., Bibby-Jones, A.-M., & Rosten, C. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.04.007 · Cited by 50

Boosting psychological change: Combining non-invasive brain stimulation with psychotherapy

Tatti, E., Phillips, A., Paciorek, R., Romanella, S. M., Dèttore, D., Lorenzo, G. D., Ruffini, G., Rossi, S., & Santarnecchi, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104867 · Cited by 54

Pharmacogenetics of Antidepressant Treatment in Obsessive–Compulsive Disorder: An Update and Implications for Clinicians

Zai, G. C., Brandl, E. J., Müller, D. J., Richter, M. A., & Kennedy, J. L. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.83 · Cited by 49

Functional disruption of cerebello-thalamo-cortical networks in obsessive-compulsive disorder

Sha, Z., Edmiston, E. K., Versace, A., Fournier, J. C., Graur, S., Greenberg, T., Lima Santos, J. P., Chase, H. W., Stiffler, R. S., Bonar, L., et al. (2020) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.002 · Cited by 48

Cognitive-behavioral therapy for obsessive–compulsive disorder: access to treatment, prediction of long-term outcome with neuroimaging

O'Neill, J., & Feusner, J. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s75106 · Cited by 48

Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders

Serretti, A., Chiesa, A., Calati, R., Perna, G., Bellodi, L., & Ronchi, D. D. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32831db2d7 · Cited by 48

Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease

Panza, F., Solfrizzi, V., Seripa, D., Imbimbo, B. P., Santamato, A., Lozupone, M., Prete, C., Greco, A., Pilotto, A., & Logroscino, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1092520 · Cited by 49

The impacts of elevated autism spectrum disorder traits on clinical and psychosocial features and long-term treatment outcome in adult patients with obsessive-compulsive disorder

三戸, 宏., Matsuura, N., Mukai, K., Yanagisawa, Y., Nakajima, A., Motoyama, M., Arikawa, A., Yamanishi, K., & Matsunaga, H. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.05.005 · Cited by 50

Does exposure and response prevention improve the results of group cognitive‐behavioural therapy for male slot machine pathological gamblers?

Jiménez‐Múrcia, S., Aymamí, N., Gómez‐Peña, M., Santamaría, J. J. V., Álvarez‐Moya, E. M., Fernández‐Aranda, F., Granero, R., Penelo, E., Bueno, B., Moragas, L., et al. (2011) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.2011.02012.x · Cited by 47

Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder

D’Addario, C., Bellia, F., Benatti, B., Grancini, B. M., Vismara, M. E. M., Pucci, M., Carlo, V. D., Viganò, C. A., Galimberti, D., Fenoglio, C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.006 · Cited by 48

Obsessive-Compulsive Personality Disorder: A Review of Symptomatology, Impact on Functioning, and Treatment

Pinto, A., Teller, J. A., & Wheaton, M. G. (2022) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20220058 · Cited by 51

New‐Onset Treatment‐Dependent Diabetes Mellitus and Hyperlipidemia Associated with Atypical Antipsychotic Use in Older Adults without Schizophrenia or Bipolar Disorder

Erickson, S. C., Le, L. B., Zakharyan, A., Stockl, K. M., Harada, A. S. M., Soo Borson, B., Ramsey, S. D., & Curtis, B. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03842.x · Cited by 46

High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey

Pampaloni, I., Sivakumaran, T., Hawley, C. J., Allaq, A. A., Farrow, J., Nelson, S., & Fineberg, N. A. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104850 · Cited by 46

Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries

Thorpe, C. T., Fowler, N. R., Harrigan, K., Zhao, X., Kang, Y., Hanlon, J. T., Gellad, W. F., Schleiden, L. J., & Thorpe, J. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14403 · Cited by 46

The effect of treatment on quality of life and functioning in OCD

Asnaani, A., Kaczkurkin, A. N., Alpert, E., McLean, C. P., Simpson, H. B., & Foa, E. B. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.10.004 · Cited by 47

Religious involvement and obsessive compulsive disorder among African Americans and Black Caribbeans

Himle, J. A., Taylor, R. J., & Chatters, L. M. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.02.003 · Cited by 46

The influence of corporate and political interests on models of illness in the evolution of the DSM

Pilecki, B. C., Clegg, J. W., & McKay, D. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.01.005 · Cited by 45

Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis

van der Straten, A. L., Denys, D. A. J. P., & van Wingen, G. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17593-7 · Cited by 45

Publication rates in animal research. Extent and characteristics of published and non-published animal studies followed up at two German university medical centres

Wieschowski, S., Biernot, S., Deutsch, S., Glage, S., Bleich, A., Tolba, R. H., & Strech, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223758 · Cited by 45

Using Motivational Interviewing to Enhance Treatment Outcome in People With Obsessive-Compulsive Disorder

Simpson, H. B., & Zuckoff, A. (2010) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2009.06.009 · Cited by 45

Symmetry concerns as a symptom of body dysmorphic disorder

Hart, A. S., & Phillips, K. A. (2013) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2013.04.004 · Cited by 44

A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes

Westbury, J., Tichelaar, L. K., Peterson, G. M., Gee, P. R., & Jackson, S. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000421 · Cited by 44

Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain

Feingold, D., Goor‐Aryeh, I., Brill, S., Delayahu, Y., & Lev‐Ran, S. (2016) · Pain Medicine · doi:10.1093/pm/pnw134 · Cited by 44

Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: Analysis of a sample of older adults with Alzheimer’s disease and vascular dementia

Pérez, E., Justo‐Henriques, S. I., & Apóstolo, J. (2021) · The Clinical Neuropsychologist · doi:10.1080/13854046.2021.1871962 · Cited by 44

Anabolic Steroid Abuse and Dependence in Clinical Practice

Brower, K. J. (2009) · The Physician and Sportsmedicine · doi:10.3810/psm.2009.12.1751 · Cited by 44

Conservative interventions for incontinence in people with dementia or cognitive impairment, living at home: a systematic review

Drennan, V. M., Greenwood, N., Cole, L., Fader, M. J., Grant, R., Rait, G., & Iliffe, S. (2012) · BMC Geriatrics · doi:10.1186/1471-2318-12-77 · Cited by 44

Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder

Fullana, M. A., Alonso, P., Gratacòs, M., Jaurrieta, N., Jiménez‐Múrcia, S., Segalàs, C., Real, E., Estivill, X., & Menchón, J. M. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.09.005 · Cited by 44

Punishment promotes response control deficits in obsessive-compulsive disorder: evidence from a motivational go/no-go task

Morein-Zamir, S., Papmeyer, M., Gillan, C. M., Crockett, M. J., Fineberg, N. A., Sahakian, B. J., & Robbins, T. W. (2013) · Psychological Medicine · doi:10.1017/s0033291712001018 · Cited by 43

Effects of general practitioner training and family support services on the care of home-dwelling dementia patients - Results of a controlled cluster-randomized study

Donath, C., Graessel, E., Großfeld-Schmitz, M., Menn, P., Lauterberg, J., Wunder, S., Marx, P., Ruckdäschel, S., Mehlig, H., & Holle, R. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-314 · Cited by 43

Exposure therapy in a virtual environment: Validation in obsessive compulsive disorder

Cullen, A. J., Dowling, N. L., Segrave, R. A., Carter, A., & Yücel, M. (2021) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102404 · Cited by 43

Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: Improvement with treatment and worsening following discontinuation

Pallanti, S., Bernardi, S., Antonini, S., Singh, N., & Hollander, E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.12.003 · Cited by 42

Childhood trauma and attachment style predict the four-year course of obsessive compulsive disorder: Findings from the Netherlands obsessive compulsive disorder study

Tibi, L., van Oppen, P., van Balkom, A. J. L. M., Eikelenboom, M., Hendriks, G., & Anholt, G. E. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.12.028 · Cited by 42

Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications

Rojas, M., Ariza, D., Ortega, Á., Riaño-Garzón, M., Chávez-Castillo, M., Pérez, J. L., Cudris–Torres, L., Bautista, M. J., Medina, Ó., Rojas, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136918 · Cited by 47

Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: A survey of 796 outpatients in Japan

Uchida, H., Suzuki, T., Mamo, D. C., Mulsant, B. H., Kikuchi, T., Takeuchi, H., Tomita, M., Watanabe, K., Yagi, G., & Kashima, H. (2008) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2008.10.003 · Cited by 42

The association between comorbid psychiatric diagnoses and hospitalization-related factors among individuals with schizophrenia

Kessler, T., & Lev‐Ran, S. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2018.12.004 · Cited by 42

Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression

Delgado-Acevedo, C., Estay, S. F., Radke, A. K., Sengupta, A., Escobar, A. P., Henríquez-Belmar, F., Reyes, C. A., Haro‐Acuña, V., Utreras, E., Sotomayor‐Zárate, R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0302-7 · Cited by 42

Drug–nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3)

Vora, B., Green, E. A. E., Khuri, N., Bällgren, F., Sirota, M., & Giacomini, K. M. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz255 · Cited by 42

Effectiveness and safety of neuroablation for severe and treatment-resistant obsessive–compulsive disorder: a systematic review and meta-analysis

Lai, Y., Wang, T., Zhang, C., Lin, G., Voon, V., Chang, J. W., & Sun, B. (2020) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190079 · Cited by 42

Non-pharmacologic treatment of insomnia in persons with dementia.

Shub, D., Darvishi, R., & Kunik, M. E. (2009) · PubMed · Cited by 42

Utility of Behavioral versus Cognitive Measures in Differentiating between Subtypes of Frontotemporal Lobar Degeneration and Alzheimer’s Disease

Heidler‐Gary, J., Gottesman, R., Newhart, M., Chang, S., Ken, L., & Hillis, A. E. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000098562 · Cited by 44

Atypical Antipsychotics for Neuropsychiatric Symptoms of Dementia

Herrmann, N., & Lanctôt, K. L. (2006) · Drug Safety · doi:10.2165/00002018-200629100-00002 · Cited by 42

A Meta-analysis of Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder

Steuber, E. R., & Mcguire, J. F. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.06.003 · Cited by 41

Prevention and Clinical Management of Hip Fractures in Patients With Dementia

Menzies, I. B., Mendelson, D. A., Kates, S. L., & Friedman, S. M. (2010) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/2151458510389465 · Cited by 41

Quantifying the Role of Adverse Events in the Mortality Difference between First and Second-Generation Antipsychotics in Older Adults: Systematic Review and Meta-Synthesis

Jackson, J. W., Schneeweiß, S., VanderWeele, T. J., & Blacker, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105376 · Cited by 42

Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design

Soto, M. E., Andrieu, S., Nourhashémi, F., Ousset, P., Ballard, C. G., Robert, P. H., Vellas, B. J., Lyketsos, C. G., & Rosenberg, P. B. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001720 · Cited by 41

Grip on challenging behaviour: a multidisciplinary care programme for managing behavioural problems in nursing home residents with dementia. Study protocol

Zwijsen, S. A., Smalbrugge, M., Zuidema, S. U., Koopmans, R. T. C. M., Bosmans, J. E., van Tulder, M. W., Eefsting, J. A., Gerritsen, D. L., & Pot, A. M. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-41 · Cited by 41

Dementia Care at End of Life: Current Approaches

Bartley, M. M., Suarez, L. S. K., Shafi, R. M. A., Baruth, J. M., Benarroch, A. J. M., & Lapid, M. I. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0915-x · Cited by 45

Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study

Saarelainen, L., Tolppanen, A., Koponen, M., Tanskanen, A. J., Tiihonen, J., Hartikainen, S. A., & Taipale, H. T. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4821 · Cited by 41

What ‘We’?

Lawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 44

Diagnosis and treatment of depression and anxiety in rural and nonrural primary care: national survey results.

Jameson, J., & Blank, M. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.6.624 · Cited by 51

Patient-Centered Communication During the Disclosure of a Dementia Diagnosis

Zaleta, A. K., & Carpenter, B. D. (2010) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317510372924 · Cited by 41

Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes From a Retrospective Longitudinal Observational Study

Feusner, J. D., Farrell, N. R., Kreyling, J., McGrath, P. B., Rhode, A., Faneuff, T., Lonsway, S., Mohideen, R., Jurich, J. E., Trusky, L., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/36431 · Cited by 40

Efficacy of group psychotherapy for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials

Schwartze, D., Barkowski, S., Burlingame, G. M., Strauss, B., & Rosendahl, J. (2016) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2016.05.001 · Cited by 40

Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder

Spencer, S. D., Stiede, J. T., Wiese, A. D., Goodman, W. K., Guzick, A. G., & Storch, E. A. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.10.004 · Cited by 43

Glutamate Modulators in the Treatment of Obsessive-Compulsive Disorder

Pittenger, C. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150602-06 · Cited by 41

Pharmacogenetics of Obsessive–Compulsive Disorders

Brandl, E. J., Müller, D. J., & Richter, M. A. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.133 · Cited by 40

Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer’s Disease Undergoing Cholinesterase Inhibitor Treatment

Cho, H. S., Huang, L. K., Lee, Y. T., Chan, L., & Hong, C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00325 · Cited by 40

The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap

Szechtman, H., Harvey, B. H., Woody, E. Z., & Hoffman, K. L. (2019) · Pharmacological Reviews · doi:10.1124/pr.119.017772 · Cited by 41

Sarcosine Therapy for Obsessive Compulsive Disorder

Wu, P.-L., Tang, H., Lane, H., Tsai, C., & Tsai, G. E. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182189878 · Cited by 40

Management of Obsessive-Compulsive Disorder

Seibell, P. J., & Hollander, E. (2014) · F1000Prime Reports · doi:10.12703/p6-68 · Cited by 40

Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting

Rector, N. A., Richter, M. A., Katz, D., & Leybman, M. (2019) · British Journal of Clinical Psychology · doi:10.1111/bjc.12188 · Cited by 39

Pre‐supplementary motor network connectivity and clinical outcome of magnetic stimulation in obsessive–compulsive disorder

Ji, G., Xie, W., Yang, T., Wu, Q., Sui, P., Bai, T., Chen, L., Chen, L., Chen, X., Dong, Y., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25468 · Cited by 39

Neuronal Glutamate Transporters Control Dopaminergic Signaling and Compulsive Behaviors

Bellini, S., Fleming, K. E., De, M., McCauley, J. P., Petroccione, M. A., D’Brant, L. Y., Tkachenko, A., Kwon, S., Jones, L. A., & Scimemi, A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1906-17.2017 · Cited by 41

Current treatments for patients with Alzheimer disease.

Osborn, G. G., & Saunders, A. V. (2010) · PubMed · Cited by 38

Computer-assisted cognitive behavior therapy for obsessive-compulsive disorder: a randomized trial on the impact of lay vs. professional coaching

Kobak, K. A., Greist, R., Jacobi, D. M., Levy-Mack, H., & Greist, J. H. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0048-0 · Cited by 38

Treatment-refractory obsessive compulsive disorder

Atmaca, M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.12.004 · Cited by 38

Body Dysmorphic Disorder: Clinical Overview and Relationship to Obsessive-Compulsive Disorder

Phillips, K. A., & Kelly, M. M. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20210012 · Cited by 44

Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial

Reid, A. M., McNamara, J. P. H., Murphy, T. K., Guzick, A. G., Storch, E. A., Geffken, G. R., & Bussing, R. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.006 · Cited by 38

A Pilot Test of the Additive Benefits of Physical Exercise to CBT for OCD

Rector, N. A., Richter, M. A., Lerman, B., & Regev, R. (2015) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2015.1016448 · Cited by 38

Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Kim, M., Kwak, S., Yoon, Y. B., Kwak, Y. B., Kim, T., Cho, K. I. K., Lee, T. Y., & Kwon, J. S. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0436-2 · Cited by 37

“On my own, but not alone”—adolescents’ experiences of internet-delivered cognitive behavior therapy for obsessive-compulsive disorder

Lenhard, F., Vigerland, S., Engberg, H., Hallberg, A., Thermaenius, H., & Serlachius, E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164311 · Cited by 37

Psychotropic drug use in community-dwelling elderly people—characteristics of persistent and incident users

Rikala, M., Korhonen, M. J., Sulkava, R. O., & Hartikainen, S. A. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-0996-5 · Cited by 37

Obsessive–compulsive Disorder: Diagnostic and Treatment Issues

Stein, D. J., Denys, D. A. J. P., Gloster, A. T., Hollander, E., Leckman, J. F., Rauch, S. L., & Phillips, K. A. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.05.007 · Cited by 37

Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder

Vakili, Y., Gharaee, B., & Habibi, M. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.17795/ijpbs845 · Cited by 37

Clinical practice guidelines as learned treatises: understanding their use as evidence in the courtroom.

Recupero, P. R. (2008) · PubMed · Cited by 37

A randomized controlled study of brief family-based intervention in obsessive compulsive disorder

Baruah, U., Pandian, R. D., Narayanaswamy, J. C., Math, S. B., Thennarasu, K., & Reddy, Y. C. J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.014 · Cited by 37

Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders

Kim, D., Ryba, N., Kalabalik, J., & Westrich, L. (2018) · Drugs in R&D · doi:10.1007/s40268-018-0246-8 · Cited by 37

Treatment of Patients With Obsessive-Compulsive Disorder

(2008) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423370.151660 · Cited by 3

Chapter 52. Treatment of Obsessive-Compulsive Disorder

Kayser, R. R., & Simpson, H. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as52 · Cited by 1

Clinical practice guideline for obsessive-compulsive disorder

Matsunaga, H. (2019) · Asian College of Neuropsychopharmacology

Obsessive-Compulsive Disorder

GELLER, D. A. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623921.md23 · Cited by 6

Obsessive-Compulsive Disorder (OCD)

(2015) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370740.umd12 · Cited by 1